Human natural killer cell expansion is regulated by thrombospondin-mediated activation of transforming growth factor-β1 and independent accessory cell-derived contact and soluble factors

Blood

Volumn 87, Issue 1, 1996, Pages 180-189

  Pierson, Bryce A ^a   Gupta, Kalpna ^a   Hu, Wet Shou ^a   Miller, Jeffrey S ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

THROMBOSPONDIN; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CELL PROLIFERATION; CYTOTOXICITY; GROWTH REGULATION; HUMAN; HUMAN CELL; IMMUNOREGULATION; IMMUNOSTIMULATION; NATURAL KILLER CELL; PRIORITY JOURNAL;

3T3 CELLS; ADULT; ANIMALS; ANTIGEN-PRESENTING CELLS; BASE SEQUENCE; BIOLOGICAL FACTORS; CELL COMMUNICATION; CELL DIVISION; CELLS, CULTURED; COCULTURE TECHNIQUES; CONNECTIVE TISSUE; CONNECTIVE TISSUE CELLS; CULTURE MEDIA, CONDITIONED; EXTRACELLULAR MATRIX; FIBROBLASTS; HUMANS; INTERLEUKIN-2; KILLER CELLS, LYMPHOKINE-ACTIVATED; KILLER CELLS, NATURAL; LEUKOCYTES, MONONUCLEAR; MEMBRANE GLYCOPROTEINS; MICE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; SOLUBILITY; THROMBOSPONDINS; TRANSFORMING GROWTH FACTOR BETA;

EID: 0030045661     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.1.180.bloodjournal871180     Document Type: Article

References (53)

1. Miller JS, Oelkers S, Verfaillie C, McGlave PB: Role of monocytes in the expansion of human activated natural killer cells. Blood 80:2221, 1992
2. Pierson BA, Miller JS, Verfaillie C, McGlave PB, Hu WS: Population dynamics of human activated natural killer cells in culture. Bioengineering Biotech 43:685, 1994
3. Pierson BA: Ex vivo expansion of human natural killer cells (NK) for adoptive immunotherapy. PhD Thesis, University of Minnesota, 1995
4. Whitlock C, Witte O: Long-term culture of B-lymphocytes and their precursors from murine bone marrow. Proc Natl Acad Sci USA 79:3608, 1982
5. Ryan DH, Nuccie BL, Abboud CN, Liesveld JL: Maturation-dependent adhesion of human B cell precursors to the bone marrow microenvironment. J Immunol 145:477, 1990
6. Dorshkind K, Landreth K: Regulation of B cell differentiation by bone marrow stromal cells. J Int Cell Clon 10:12, 1992
7. Mamabe A, Coustan-Smith E, Behm FG, Raimondi SC, Campana D: Bone marrow-derived stromal cells prevent apoptotic cell death in B-lineage acute lymphoblaslic leukemia. Blood 79:2370, 1992
8. Savion S, Itoh T, Hertogs H, Shoham J: Contact-mediated maturational effects of thymic stromal cells on murine thymocytes in culture Immunology 67:496, 1989
9. - primitive progenitors in long-term bone marrow culture. Blood 80:2182, 1992
10. + NK progenitor. Blood 83:2594, 1994
11. Sitnicka E, Hannson M: Natural killer cell activity in human long-term bone marrow cultures: Effects of IL-2 and granulocyte-macrophage colony stimulating factor on progenitor cells. Immunology 76:292, 1992
12. Jaffe EA, Ruggiero JT, Falcone DJ: Monocytes and macrophages synthesize and secrete thrombospondin. Blood 65:79, 1985
13. Jaffe EA, Ruggiero JT, Leung LLK, Doyle MJ, McKeown-Longo PJ, Mosher DF: Cultured human fibroblasts synthesize and secrete thrombospondin and incorporate it into extracellular matrix. Proc Natl Acad Sci USA 80:998, 1983
14. Hunter NR, Dawes I, MacGregor IR, Pepper DS: Quantitation by radioimmunoassay of thrombospondin synthesized and secreted by human endothelial cells. Thromb Heamost 52:288, 1984
15. Castle V, Varani J, Flifiel S, Prochownik EV, Dixit V: Antisense-mediated reduction in thrombospondin reverses the malignant phenotype of a human squamous carcinoma. J Clin Invest 87:1883, 1991
16. Roberts RA, Spooncer E, Parkinson EK, Lord BI, Allen TD, Dexter TM: Metabollically inactive 3T3 cells can substitute for marrow stromal cells to promote the proliferation and development of multipotent haemopoietic stem cells. J Cell Physiol 132:203, 1987
17. Nagler A, Lamer LL, Cwirla S, Phillips JH: Comparative studies of human FcRIII-positive and negative natural killer cells. J Immunol 143.3183, 1989
18. Pierson BA, McGlave PB, Hu WS, Miller JS: Natural killer cell proliferation is dependent on human serum and is markedly increased utilizing an enriched supplemented basal medium. J Hematother 4:149, 1995
19. Pearse AGE: Preparation and Optical Technology, vol 1 (ed 4). New York, NY, Churchill Livingstone, 1980
20. Culling CFA, Allison RT, Barr WT: Fixation in Cellular Pathology Techniques (ed 4). London, UK, Butterworth and Company, 1985
21. McCarthy JB, Hagen ST, Furcht LT: Human flbronectin contains distinct adhesion- and motility-promoting domains for metastatic melanoma cells. J Cell Biol 102:179, 1986
22. Skubitz AP, McCarthy JB, Zhao Q, Yi X, Furcht LT: Definition of a sequence RYVVLPR, within laminin peptide F-9 that mediates metastatic fibrosarcoma cell adhesion and spreading. Cancer Res 50:7612, 1990
23. Sun X, Mosher DF, Rapraeger A: Heparan sulfate-mediated binding of epithelial cell surface proteoglycan to thrombospondin. J Biol Chem 264:2886, 1989
24. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenolchloroform extraction. Ann Biochem 162:156, 1987
25. Murphy-Ullrich JE, Schultz-Cherry S, Hook M: Transforming growth factor-β complexes with thrombospondin. Mol Biol Cell 3:181, 1992
26. Schultz-Cherry S, Murphy-Ullrich JE: Thrombospondin causes activation of latent transforming growth factor-β secreted by endothelial cells by a novel mechanism. J Cell Biol 122:923, 1993
27. Schultz-Cherry S, Ribeiro S, Gentry L, Murphy-Ullrich JE: Thrombospondin binds and activates the small and large forms of latent transforming growth factor-β in a chemically defined system. J Biol Chem 269:26775, 1994
28. Schultz-Cherry S, Lawler J, Murphy-Ullrich JE: The type 1 repeats of thrombospondin 1 activate latent transforming growth factor-β. J Biol Chem 269:26783, 1994
29. 2+ on FcγRIII (CD16)-induced transcription and expression of lymphokine genes. J Exp Med 169:549, 1989
30. Lanier LL, Ruitenberg JJ, Phillips JH: Functional and biochemical analysis of CD16 antigen on natural killer cells and granulocytes. J Immunol 141:3478, 1988
31. Wakefield LM, Letterio JJ, Chen T, Sporn MB: Quantitation and characterization of transforming growth factor-β subtypes in human serum and plasma. Proc Am Assoc Cancer Res 34:239a, 1993 (abstr)
32. Perussia B, Ramoni C, Anegon I, Cuturi MC, Faust J, Trinchieri G: Preferential proliferation of natural killer cells among peripheral blood mononuclear cells cocultured with B lymphoblastoid cell lines. Natl Immunol Cell Growth Regul 6:171, 1987
33. Rabinowich H, Sedlmayr P, Herberman RB, Whiteside TL: Increased proliferation, lytic activity and purity of human natural killer cells cocultured with mitogen-activated feeder cells. Cell Immunol 135:454, 1991
34. Robertson MJ, Manley TJ, Donahue C, Levine H, Ritz J: Costimulatory signals are required for optimal proliferation of human natural killer cells. J Immunol 150:1705, 1993
35. Springer TA: Adhesion receptors of the immune system. Nature 346:425, 1990
36. Vitolo D, Vujanovic NL, Rabinowich H, Schlesinger M, Herberman RB, Whiteside TL: Rapid IL-2 induced adherence of human natural killer cells: Expression of mRNA for cytokines and IL-2 receptors in adherent NK cells. J Immunol 151:1926, 1993
37. Massague J: The transforming growth factor-β family. Annu Rev Cell Biol 6:597, 1990
38. Moses HL, Tucker RF, Leof EB, Coffey RJ, Halper J, Shipley GD: Type β transforming growth factor is a growth stimulator and growth inhibitor, in Feramisco J, Ozanne B, Stiles C (eds): Cancer Cells, vol 3. Cold Spring Harbor, NY, Cold Spring Harbor Press, 1985, p 65
39. Roberts AB, Anzano MA, Wakefield LM, Roche NS, Stern DF, Sporn MB: Type-β transforming growth factor: A bifunctional regulator of cellular growth. Proc Natl Acad Sci USA 82:119, 1985
40. Kehrl JH, Roberts AB, Wakefield LM, Jakowlew S, Sporn MB, Fauci AS: Transforming growth factor-β is an important immunomodulatory protein for human B lymphocytes. J Immunol 137:3855, 1986
41. Kehrl JH, Wakefield LM, Roberts AB, Jakplew SB, Alverez-Mon M: Production of transforming growth factor-β by human T lymphocytes and its potential role in the regulation of T cell growth. J Exp Med 163:1037, 1986
42. Ristow HJ: BSC-1 growth inhibitor type β transforming growth factor is a strong inhibitor of thymocyte proliferation. Proc Natl Acad Sci USA 83:5531, 1986
43. Heimark RL, Twardzik DR, Schwarz SM: Inhibition of endothelial cell regeneration by beta-type transforming growth factor from platelets. Science 233:1078, 1986
44. Laiho M, DeCaprio JA, Ludlow JW, Livingston DM, Massague J: Growth inhibition by TGF-β linked to suppression of retinoblastoma protein phosphorylation. Cell 62:175, 1990
45. Nakamura T, Tomita Y, Hirai R, Kaji K, Ichihara A: Inhibitory effect of transforming growth factor-β on DNA synthesis of adult rat hepatocytes in primary culture. Biochem Biophys Res Commun 133:1042, 1990
46. Shipley GD, Tucker RF, Moses HL: Type β-transforming growth factor/growth inhibitor stimulates cultures of AKR-2B cells into S-phase after prolonged prereplicative interval. Proc Natl Acad Sci USA 82:4147, 1985
47. Moses HL, Branum EL, Proper J, Robinson RA: Transforming growth factor production by chemically transformed cells. Cancer Res 41:2842, 1981
48. Massague J: Type β transforming growth factor from feline sarcoma virus-transformed rat cells. J Biol Chem 259:9756, 1981
49. Bassols A, Massague J: Transforming growth factor-β regulates the expression and structure of extracellular matrix chondroitin/ dermatan sulfate proteoglycans. J Biol Chem 263:3039, 1988
50. Ignotz RA, Massague J: Transforming growth factor-β stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem 261:4337, 1986
51. Ishizaka S, Yoshikawa M, Tsujii T: Immunoregulatory effects of transforming growth factor-β in a prolonged period of culture. Cell Immunol 139.239, 1992
52. Arteaga CL, Hurd SD, Winnier AR, Johnson MD, Fendly BM, Forbes JT: Anti-transforming growth factor (TGF)-β antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity. J Clin Invest 92:2569, 1993
53. - large granular lymphocyte functions: Regulation of IL-2Rβ (p75) signal transduction. J Immunol 146:3791, 1991